Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2002 15
2003 11
2004 10
2005 12
2006 16
2007 15
2008 26
2009 20
2010 25
2011 29
2012 31
2013 59
2014 44
2015 38
2016 43
2017 41
2018 35
2019 35
2020 55
2021 59
2022 31
Text availability
Article attribute
Article type
Publication date

Search Results

575 results
Results by year
Filters applied: . Clear all
Page 1
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).
Miller DS, Filiaci VL, Mannel RS, Cohn DE, Matsumoto T, Tewari KS, DiSilvestro P, Pearl ML, Argenta PA, Powell MA, Zweizig SL, Warshal DP, Hanjani P, Carney ME, Huang H, Cella D, Zaino R, Fleming GF. Miller DS, et al. Among authors: matsumoto t. J Clin Oncol. 2020 Nov 20;38(33):3841-3850. doi: 10.1200/JCO.20.01076. Epub 2020 Sep 29. J Clin Oncol. 2020. PMID: 33078978 Free PMC article. Clinical Trial.
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).
Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, Nakao S, Saito T, Enomoto T, Nagase S, Suzuki N, Matsumoto T, Kondo E, Sonoda K, Aihara S, Aoki Y, Okamoto A, Takano H, Kobayashi H, Kato H, Terai Y, Takazawa A, Takahashi Y, Namba Y, Aoki D, Fujiwara K, Sugiyama T, Konishi I. Hamanishi J, et al. Among authors: matsumoto t. J Clin Oncol. 2021 Nov 20;39(33):3671-3681. doi: 10.1200/JCO.21.00334. Epub 2021 Sep 2. J Clin Oncol. 2021. PMID: 34473544 Clinical Trial.
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.
Fujiwara K, Fujiwara H, Yoshida H, Satoh T, Yonemori K, Nagao S, Matsumoto T, Kobayashi H, Bourgeois H, Harter P, Mosconi AM, Vazquez IP, Reinthaller A, Fujita T, Rowe P, Pujade-Lauraine E, Ray-Coquard I. Fujiwara K, et al. Among authors: matsumoto t. J Gynecol Oncol. 2021 Sep;32(5):e82. doi: 10.3802/jgo.2021.32.e82. J Gynecol Oncol. 2021. PMID: 34378365 Free PMC article. Clinical Trial.
Improvement of the Oryza sativa Nipponbare reference genome using next generation sequence and optical map data.
Kawahara Y, de la Bastide M, Hamilton JP, Kanamori H, McCombie WR, Ouyang S, Schwartz DC, Tanaka T, Wu J, Zhou S, Childs KL, Davidson RM, Lin H, Quesada-Ocampo L, Vaillancourt B, Sakai H, Lee SS, Kim J, Numa H, Itoh T, Buell CR, Matsumoto T. Kawahara Y, et al. Among authors: matsumoto t. Rice (N Y). 2013 Feb 6;6(1):4. doi: 10.1186/1939-8433-6-4. Rice (N Y). 2013. PMID: 24280374 Free PMC article.
Takotsubo syndrome following MitraClip procedure.
Nomura T, Munehisa Y, Nakashima M, Matsumoto T. Nomura T, et al. Among authors: matsumoto t. Eur Heart J Case Rep. 2020 Nov 9;4(6):1-2. doi: 10.1093/ehjcr/ytaa384. eCollection 2020 Dec. Eur Heart J Case Rep. 2020. PMID: 33634224 Free PMC article. No abstract available.
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.
Yamashita T, Shiota M, Machidori A, Kobayashi S, Matsumoto T, Monji K, Kashiwagi E, Takeuchi A, Takahashi R, Inokuchi J, Shiga KI, Yokomizo A, Eto M. Yamashita T, et al. Among authors: matsumoto t. Cancer Invest. 2021 Mar;39(3):251-256. doi: 10.1080/07357907.2020.1871486. Epub 2021 Jan 14. Cancer Invest. 2021. PMID: 33393849 Clinical Trial.
Chemical Bonding in Polarised Push-Pull Ethylenes.
Yanai H, Suzuki T, Kleemiss F, Fukaya H, Dobashi Y, Malaspina LA, Grabowsky S, Matsumoto T. Yanai H, et al. Among authors: matsumoto t. Angew Chem Int Ed Engl. 2019 Jun 24;58(26):8839-8844. doi: 10.1002/anie.201904176. Epub 2019 May 24. Angew Chem Int Ed Engl. 2019. PMID: 31025431
575 results